Results From the Combined Stack No controlled human trial has published weight-loss, body-composition, safety, or metabolic results for a retatrutide and MOTS-c combination
Cell Metab 26:343352.e342 Frias JP, Nauck MA, Van J et al (2018) Efficacy and safety of LY3298176, a novel dual GIP and GLP-1 receptor agonist, in patients with type 2 diabetes: a randomised, placebo-controlled and active comparator-controlled phase 2 trial
National Academy Press, 1989
These medications help regulate your appetite, improve your metabolism and lead to sustainable weight loss
Avoid the consumption of beverages, especially coffee, seafood and alcohol during the treatment course
How GLP-1 Pills Control Blood Sugar Once the GLP-1 medication is absorbed into your bloodstream, it begins working through several mechanisms to help control blood sugar levels